Aachen smoking cessation and harm reduction (ASCHR) trial study protocol – scientific evaluation of a psychological-telemedical counseling concept for smoking cessation in patients with vascular diseases

Sebastian Scheliga,Mara Derissen,Knut Kröger,Rainer Röhrig,Lea Schomacher,Hannah Schick,Rainer Beckers,Hinrich Böhner,Ute Habel
DOI: https://doi.org/10.1186/s12889-024-20192-7
IF: 4.5
2024-10-03
BMC Public Health
Abstract:Smoking is a major risk factor of cardiovascular diseases, notably peripheral arterial disease (PAD). Despite this link, research on smoking cessation interventions in PAD patients remains scarce and inconclusive regarding the efficacy of such interventions.
public, environmental & occupational health
What problem does this paper attempt to address?